These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15287722)

  • 21. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
    Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the distal C162S mutation on the energetics of drug binding to p38alpha MAP kinase.
    Todorova NA; Doseeva V; Ramprakash J; Schwarz FP
    Arch Biochem Biophys; 2008 Jan; 469(2):232-42. PubMed ID: 17996717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p38 MAP kinase inhibitors: many are made, but few are chosen.
    Dominguez C; Powers DA; Tamayo N
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):421-30. PubMed ID: 16022178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease.
    Saklatvala J
    Curr Opin Pharmacol; 2004 Aug; 4(4):372-7. PubMed ID: 15251131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the catalytic mechanism of the p21-activated protein kinase PAK2.
    Wu H; Zheng Y; Wang ZX
    Biochemistry; 2003 Feb; 42(4):1129-39. PubMed ID: 12549935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitogen-activated protein kinase (MAPK) blockade of bovine preimplantation embryogenesis requires inhibition of both p38 and extracellular signal-regulated kinase (ERK) pathways.
    Madan P; Calder MD; Watson AJ
    Reproduction; 2005 Jul; 130(1):41-51. PubMed ID: 15985630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p38 map kinase substrate specificity differs greatly for protein and peptide substrates.
    Hawkins J; Zheng S; Frantz B; LoGrasso P
    Arch Biochem Biophys; 2000 Oct; 382(2):310-3. PubMed ID: 11068883
    [No Abstract]   [Full Text] [Related]  

  • 28. The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity.
    Goto S; Yao Z; Proud CG
    Biochem J; 2009 Sep; 423(2):279-90. PubMed ID: 19650764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
    Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel strategies for inhibition of the p38 MAPK pathway.
    Zhang J; Shen B; Lin A
    Trends Pharmacol Sci; 2007 Jun; 28(6):286-95. PubMed ID: 17482683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures of the Mnk2 kinase domain reveal an inhibitory conformation and a zinc binding site.
    Jauch R; Jäkel S; Netter C; Schreiter K; Aicher B; Jäckle H; Wahl MC
    Structure; 2005 Oct; 13(10):1559-68. PubMed ID: 16216586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease.
    Feng YJ; Li YY
    J Dig Dis; 2011 Oct; 12(5):327-32. PubMed ID: 21955425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of DnaK's lid strengthens binding to the nucleotide exchange factor, GrpE: a kinetic and thermodynamic analysis.
    Chesnokova LS; Slepenkov SV; Protasevich II; Sehorn MG; Brouillette CG; Witt SN
    Biochemistry; 2003 Aug; 42(30):9028-40. PubMed ID: 12885236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions.
    Tanoue T; Maeda R; Adachi M; Nishida E
    EMBO J; 2001 Feb; 20(3):466-79. PubMed ID: 11157753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.
    Akella R; Min X; Wu Q; Gardner KH; Goldsmith EJ
    Structure; 2010 Dec; 18(12):1571-8. PubMed ID: 21134636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase.
    Trejo A; Arzeno H; Browner M; Chanda S; Cheng S; Comer DD; Dalrymple SA; Dunten P; Lafargue J; Lovejoy B; Freire-Moar J; Lim J; Mcintosh J; Miller J; Papp E; Reuter D; Roberts R; Sanpablo F; Saunders J; Song K; Villasenor A; Warren SD; Welch M; Weller P; Whiteley PE; Zeng L; Goldstein DM
    J Med Chem; 2003 Oct; 46(22):4702-13. PubMed ID: 14561090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dog.
    Morris DL; O'Neil SP; Devraj RV; Portanova JP; Gilles RW; Gross CJ; Curtiss SW; Komocsar WJ; Garner DS; Happa FA; Kraus LJ; Nikula KJ; Monahan JB; Selness SR; Galluppi GR; Shevlin KM; Kramer JA; Walker JK; Messing DM; Anderson DR; Mourey RJ; Whiteley LO; Daniels JS; Yang JZ; Rowlands PC; Alden CL; Davis JW; Sagartz JE
    Toxicol Pathol; 2010 Jun; 38(4):606-18. PubMed ID: 20448081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer.
    Haar ET; Prabakhar P; Liu X; Lepre C
    J Biol Chem; 2007 Mar; 282(13):9733-9739. PubMed ID: 17255097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationship of aminobenzophenones. A novel class of p38 MAP kinase inhibitors with high antiinflammatory activity.
    Ottosen ER; Sørensen MD; Björkling F; Skak-Nielsen T; Fjording MS; Aaes H; Binderup L
    J Med Chem; 2003 Dec; 46(26):5651-62. PubMed ID: 14667219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.